Copy Link Print Information

Baslisiran

Baslisiran is an angiotensinogen (AGT) synthesis inhibitor that can be used in studies related to hypertension.

Para uso exclusivo en investigación. No vendemos a pacientes.

  • No. CAS: 3080217-81-5
  • Fòrmula: C498H668F8N165O314P43S7
  • Peso molecular:15697.84
  • Almacenamiento:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Baslisiran Chemical Structure
    Baslisiran Chemical Structure
No. CAS: 3080217-81-5
Tamaño
Precio
Stock
Cantidad
Amount: USD 0.00
Please select quantity
or
or

* Seleccione Cantidad antes de agregar artículos.

To place orders, for customer services and technical support, please contact: MedChemExpress USA

Tel: 609-228-6898 E-mail: [email protected] [email protected]

Data Download

To place orders, for customer services and technical support, please contact:

609-228-6898
[email protected] [email protected]
Encuentre su distribuidor local Your local distributor: Hycultec GmbHHycultec
  • Actividad biológica
  • Chemical Information
  • Protocolo
  • Pureza y Documentación
  • Referencias
  • Help & FAQs
Top Publications Citing

Use of MCE Products

Keywords

MOQ
Minimum order quantity
100 mg

Obtener un presupuesto En stock

Other size
Obtener un presupuesto
Please select quantity
Amount: USD 0.00
Sign in to MedChemExpress Inicie sesiòn
Registrar
Sign in to MedChemExpress
Registrar una cuenta nueva

At least 6 characters

Personalize your experience, you are currently not signed in. For a better experience, please create an online profile, you can:

Obtain points redemption prizes
Check out faster
Add multiple shipping locations
View orders
Assay Types
  • Baslisiran Chemical Structure
    Baslisiran Chemical Structure RNA, ([1′-de(6-amino-9H-purin-9-yl)]dA-(5′→5′)-sp-Cm-Am-Cm-Cm-Am-Gm-Cm-Um-(2′-deoxy-2′-fluoro)U-Gm-(2′-deoxy-2′-fluoro)U-Um-(2′-deoxy-2′-fluoro)U-Gm-Um-Gm-Am-Am-Am-Cm-Am-(3′→3′)-sp-[1′-de(6-amino-9H-purin-9-yl)]dA), 3′-[O-[1-[18-[[2-(acetylamino)-2-deoxy-β-D-galactopyranosyl]oxy]-6,10-bis[2-[[2-[2-[[2-(acetylamino)-2-deoxy-β-D-galactopyranosyl]oxy]ethoxy]ethyl]amino]-2-oxoethyl]-1,5,12-trioxo-16-oxa-6,10,13-triazaoctadec-1-yl]-4-piperidinyl] hydrogen phosphorothioate], complex with RNA (Um-sp-(2′-deoxy-2′-fluoro)G-sp-Um-Um-Um-Cm-(2′-deoxy-2′-fluoro)A-Cm-Am-Am-Am-(2′-deoxy-2′-fluoro)C-Am-(2′-deoxy-2′-fluoro)A-Gm-(2′-deoxy-2′-fluoro)C-Um-Gm-Gm-sp-Um-sp-Gm) (1:1)
    1/16
  • RNA, ([1′-de(6-amino-9H-purin-9-yl)]dA-(5′→5′)-sp-Cm-Am-Cm-Cm-Am-Gm-Cm-Um-(2′-deoxy-2′-fluoro)U-Gm-(2′-deoxy-2′-fluoro)U-Um-(2′-deoxy-2′-fluoro)U-Gm-Um-Gm-Am-Am-Am-Cm-Am-(3′→3′)-sp-[1′-de(6-amino-9H-purin-9-yl)]dA), 3′-[O-[1-[18-[[2-(acetylamino)-2-deoxy-β-D-galactopyranosyl]oxy]-6,10-bis[2-[[2-[2-[[2-(acetylamino)-2-deoxy-β-D-galactopyranosyl]oxy]ethoxy]ethyl]amino]-2-oxoethyl]-1,5,12-trioxo-16-oxa-6,10,13-triazaoctadec-1-yl]-4-piperidinyl] hydrogen phosphorothioate], complex with RNA (Um-sp-(2′-deoxy-2′-fluoro)G-sp-Um-Um-Um-Cm-(2′-deoxy-2′-fluoro)A-Cm-Am-Am-Am-(2′-deoxy-2′-fluoro)C-Am-(2′-deoxy-2′-fluoro)A-Gm-(2′-deoxy-2′-fluoro)C-Um-Gm-Gm-sp-Um-sp-Gm) (1:1)